110 related articles for article (PubMed ID: 8015640)
1. Increased excretion of urinary transforming growth factor beta in patients with focal glomerular sclerosis.
Kanai H; Mitsuhashi H; Ono K; Yano S; Naruse T
Nephron; 1994; 66(4):391-5. PubMed ID: 8015640
[TBL] [Abstract][Full Text] [Related]
2. Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy.
Haramaki R; Tamaki K; Fujisawa M; Ikedo H; Haramaki N; Okuda S
Am J Kidney Dis; 2001 Dec; 38(6):1191-8. PubMed ID: 11728950
[TBL] [Abstract][Full Text] [Related]
3. Urinary interleukin-6 (IL-6) and transforming growth factor (TGF-β) levels in corticosteroidtreated patients with IgA nephropathy.
Kalliakmani P; Nakopoulou L; Tsakas S; Gerolymos M; Papasotiriou M; Goumenos DS
Clin Nephrol; 2011 Aug; 76(2):144-50. PubMed ID: 21762647
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta (TGF beta) activity in urine of patients with glomerulonephritis.
Dominguez GC; Costa RS; Dantas M; Kimachi T; Coimbra TM
Braz J Med Biol Res; 1995 Oct; 28(10):1061-4. PubMed ID: 8634677
[TBL] [Abstract][Full Text] [Related]
5. Urinary transforming growth factor-beta 1 in membranous glomerulonephritis.
Honkanen E; Teppo AM; Törnroth T; Groop PH; Grönhagen-Riska C
Nephrol Dial Transplant; 1997 Dec; 12(12):2562-8. PubMed ID: 9430852
[TBL] [Abstract][Full Text] [Related]
6. Urinary transforming growth factor-beta in patients with glomerular diseases.
Murakami K; Takemura T; Hino S; Yoshioka K
Pediatr Nephrol; 1997 Jun; 11(3):334-6. PubMed ID: 9203185
[TBL] [Abstract][Full Text] [Related]
7. Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria.
Wasilewska A; Zoch-Zwierz W; Taranta-Janusz K; Kołodziejczyk Z
Scand J Urol Nephrol; 2011 Feb; 45(1):52-9. PubMed ID: 21034351
[TBL] [Abstract][Full Text] [Related]
8. Urinary transforming growth factor-beta 1 in various types of nephropathy.
De Muro P; Faedda R; Fresu P; Masala A; Cigni A; Concas G; Mela MG; Satta A; Carcassi A; Sanna GM; Cherchi GM
Pharmacol Res; 2004 Mar; 49(3):293-8. PubMed ID: 14726227
[TBL] [Abstract][Full Text] [Related]
9. Glomerular transforming growth factor-beta1 mRNA as a marker of glomerulosclerosis-application in renal biopsies.
Yang CW; Hsueh S; Wu MS; Lai PC; Huang JY; Wu CH; Hu SA; Chen JF; Huang CC
Nephron; 1997; 77(3):290-7. PubMed ID: 9375822
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria.
Goumenos DS; Tsakas S; El Nahas AM; Alexandri S; Oldroyd S; Kalliakmani P; Vlachojannis JG
Nephrol Dial Transplant; 2002 Dec; 17(12):2145-52. PubMed ID: 12454225
[TBL] [Abstract][Full Text] [Related]
11. Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis.
Honkanen EO; Teppo AM; Grönhagen-Riska C
Kidney Int; 2000 Jun; 57(6):2343-9. PubMed ID: 10844604
[TBL] [Abstract][Full Text] [Related]
12. Elevated urinary excretion of the C5b-9 complex in membranous nephropathy.
Schulze M; Donadio JV; Pruchno CJ; Baker PJ; Johnson RJ; Stahl RA; Watkins S; Martin DC; Wurzner R; Gotze O
Kidney Int; 1991 Sep; 40(3):533-8. PubMed ID: 1787650
[TBL] [Abstract][Full Text] [Related]
13. LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.
Surin B; Sachon E; Rougier JP; Steverlynck C; Garreau C; Lelongt B; Ronco P; Piedagnel R
Proteomics; 2013 Jan; 13(1):142-52. PubMed ID: 23161552
[TBL] [Abstract][Full Text] [Related]
14. Increased urinary transforming growth factor-beta(1) excretion in children with posterior urethral valves.
MacRae Dell K; Hoffman BB; Leonard MB; Ziyadeh FN; Schulman SL
Urology; 2000 Aug; 56(2):311-4. PubMed ID: 10925100
[TBL] [Abstract][Full Text] [Related]
15. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy.
Haubitz M; Wittke S; Weissinger EM; Walden M; Rupprecht HD; Floege J; Haller H; Mischak H
Kidney Int; 2005 Jun; 67(6):2313-20. PubMed ID: 15882273
[TBL] [Abstract][Full Text] [Related]
16. T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome?
Kalavrizioti D; Gerolymos M; Rodi M; Kalliakmani P; Provatopoulou S; Eleftheriadis T; Mouzaki A; Goumenos DS
Cytokine; 2015 Dec; 76(2):260-269. PubMed ID: 26307557
[TBL] [Abstract][Full Text] [Related]
17. Urinary crosslinked fibrin degradation products in glomerular disease.
Kamitsuji H; Whitworth JA; Dowling JP; Kincaid-Smith P
Am J Kidney Dis; 1986 Jun; 7(6):452-5. PubMed ID: 3717150
[TBL] [Abstract][Full Text] [Related]
18. Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis.
Fornasieri A; Perugini C; Seccia M; Napodano P; D'Amico G; Bellomo G
J Nephrol; 2002; 15(4):349-57. PubMed ID: 12243363
[TBL] [Abstract][Full Text] [Related]
19. Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy.
Sato H; Iwano M; Akai Y; Kurioka H; Kubo A; Yamaguchi T; Hirata E; Kanauchi M; Dohi K
Am J Nephrol; 1998; 18(6):490-4. PubMed ID: 9845822
[TBL] [Abstract][Full Text] [Related]
20. Elevated macrophage migration inhibitory factor (MIF) levels in the urine of patients with focal glomerular sclerosis.
Matsumoto K; Maruyama N; Maruyama T; Ohnishi Y; Nonaka S; Inoshita A; Ito K; Kitajima S; Abe M; Satomura A; Fujita T
Clin Exp Immunol; 2005 Feb; 139(2):338-47. PubMed ID: 15654833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
